| 1 |
33438033 | In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model. | 2021 Mar 12 |
1 |
| 2 |
31954597 | In vitro activity of ceftolozane/tazobactam against phenotypically defined extended-spectrum β-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016). | 2020 Apr |
3 |
| 3 |
31190913 | Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort. | 2019 |
1 |
| 4 |
31225611 | ESBLs and resistance to ceftazidime/avibactam and ceftolozane/tazobactam combinations in Escherichia coli and Pseudomonas aeruginosa. | 2019 Jul 1 |
2 |
| 5 |
31270992 | Comparison of Escherichia coli and Klebsiella pneumoniae Acute Pyelonephritis in Korean Patients. | 2019 Jun |
1 |
| 6 |
29112760 | Improvement of Bolton broth by supplementation with tazobactam for the isolation of Campylobacter from chicken rinses. | 2018 Jan 1 |
3 |
| 7 |
30033423 | Phenotypic expression and prevalence of multi drug resistant extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae in Karachi, Pakistan. | 2018 Jul |
1 |
| 8 |
30534919 | [Evaluation of susceptibility and response to therapy with piperacillin-tazobactam in patients with infections caused by Escherichia coli with extended-spectrum β-lactamase (ESBL) CTX-M]. | 2018 Aug |
1 |
| 9 |
27707990 | Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials. | 2017 Jan |
5 |
| 10 |
28391954 | Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015. | 2017 Jun |
1 |
| 11 |
26552975 | Pharmacodynamics of Ceftolozane plus Tazobactam Studied in an In Vitro Pharmacokinetic Model of Infection. | 2016 Jan |
1 |
| 12 |
25398058 | Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children. | 2015 Apr |
1 |
| 13 |
22808728 | [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains]. | 2012 |
1 |
| 14 |
19349512 | In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. | 2009 Jun |
1 |
| 15 |
18059098 | Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. | 2008 |
3 |
| 16 |
18792814 | beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes. | 2008 Sep |
1 |
| 17 |
19255989 | In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. | 2008 Oct |
1 |
| 18 |
11758235 | [Clinical analysis of nosocomial infection of extended spectrum beta-lactamase-producing bacteria]. | 2001 Sep |
3 |